LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Seres Therapeutics Inc

Closed

SectorHealthcare

8.09 14.91

Overview

Share price change

24h

Current

Min

6.98

Max

8.22

Key metrics

By Trading Economics

Income

48M

33M

EPS

-2.238

Employees

103

EBITDA

-15M

-27M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+83.61% upside

Dividends

By Dow Jones

Next Earnings

12 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-23M

61M

Previous open

-6.82

Previous close

8.09

News Sentiment

By Acuity

69%

31%

347 / 380 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Seres Therapeutics Inc Chart

Past performance is not a reliable indicator of future results.

Related News

6 Jun 2024, 10:30 UTC

Acquisitions, Mergers, Takeovers

Seres Therapeutics Enters Into Memorandum of Understanding for Vowst Asset Sale to Nestlé Health Science

Peer Comparison

Price change

Seres Therapeutics Inc Forecast

Price Target

By TipRanks

83.61% upside

12 Months Forecast

Average 13.33 USD  83.61%

High 20 USD

Low 6 USD

Based on 4 Wall Street analysts offering 12 month price targets forSeres Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

4 ratings

2

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

N/A / 9.31Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Bearish Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

347 / 380 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Above average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$